IBDEI1RZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30172,1,3,0)
 ;;=3^Hodgkin lymphoma, unspecified, unspecified site
 ;;^UTILITY(U,$J,358.3,30172,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,30172,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,30173,0)
 ;;=C82.69^^118^1502^17
 ;;^UTILITY(U,$J,358.3,30173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30173,1,3,0)
 ;;=3^Cutan folicl center lymphoma, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,30173,1,4,0)
 ;;=4^C82.69
 ;;^UTILITY(U,$J,358.3,30173,2)
 ;;=^5001530
 ;;^UTILITY(U,$J,358.3,30174,0)
 ;;=C82.60^^118^1502^18
 ;;^UTILITY(U,$J,358.3,30174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30174,1,3,0)
 ;;=3^Cutaneous follicle center lymphoma, unspecified site
 ;;^UTILITY(U,$J,358.3,30174,1,4,0)
 ;;=4^C82.60
 ;;^UTILITY(U,$J,358.3,30174,2)
 ;;=^5001521
 ;;^UTILITY(U,$J,358.3,30175,0)
 ;;=C82.49^^118^1502^33
 ;;^UTILITY(U,$J,358.3,30175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30175,1,3,0)
 ;;=3^Follicular lymphoma grade IIIb, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,30175,1,4,0)
 ;;=4^C82.49
 ;;^UTILITY(U,$J,358.3,30175,2)
 ;;=^5001510
 ;;^UTILITY(U,$J,358.3,30176,0)
 ;;=C82.40^^118^1502^34
 ;;^UTILITY(U,$J,358.3,30176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30176,1,3,0)
 ;;=3^Follicular lymphoma grade IIIb, unspecified site
 ;;^UTILITY(U,$J,358.3,30176,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,30176,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,30177,0)
 ;;=C82.19^^118^1502^28
 ;;^UTILITY(U,$J,358.3,30177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30177,1,3,0)
 ;;=3^Follicular lymphoma grade II, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,30177,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,30177,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,30178,0)
 ;;=C82.39^^118^1502^31
 ;;^UTILITY(U,$J,358.3,30178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30178,1,3,0)
 ;;=3^Follicular lymphoma grade IIIa, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,30178,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,30178,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,30179,0)
 ;;=C82.30^^118^1502^32
 ;;^UTILITY(U,$J,358.3,30179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30179,1,3,0)
 ;;=3^Follicular lymphoma grade IIIa, unspecified site
 ;;^UTILITY(U,$J,358.3,30179,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,30179,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,30180,0)
 ;;=C82.29^^118^1502^25
 ;;^UTILITY(U,$J,358.3,30180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30180,1,3,0)
 ;;=3^Follicular lymph grade III, unsp, extrnod and solid org sites
 ;;^UTILITY(U,$J,358.3,30180,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,30180,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,30181,0)
 ;;=C82.20^^118^1502^30
 ;;^UTILITY(U,$J,358.3,30181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30181,1,3,0)
 ;;=3^Follicular lymphoma grade III, unspecified, unspecified site
 ;;^UTILITY(U,$J,358.3,30181,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,30181,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,30182,0)
 ;;=C82.09^^118^1502^26
 ;;^UTILITY(U,$J,358.3,30182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30182,1,3,0)
 ;;=3^Follicular lymphoma grade I, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,30182,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,30182,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,30183,0)
 ;;=C82.10^^118^1502^29
 ;;^UTILITY(U,$J,358.3,30183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30183,1,3,0)
 ;;=3^Follicular lymphoma grade II, unspecified site
 ;;^UTILITY(U,$J,358.3,30183,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,30183,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,30184,0)
 ;;=C82.00^^118^1502^27
 ;;^UTILITY(U,$J,358.3,30184,1,0)
 ;;=^358.31IA^4^2
